Variability of Oxaliplatin-Induced Neuropathic Pain Symptoms in Each Cycle and Its Implications on the Management of Colorectal Cancer Patients: A Retrospective Study in South Western Sydney Local Health District Hospitals, Sydney, Australia

<div>Number of patients who received dose reduction for a single drug or combinations of drugs in each cycle irrespective of the type of treatment regimens. Fluorouracil (FU); folinic acid (FA); XELOX: oxaliplatin + capecitabine.</div>

Journal of Oncology

fig4

Figure 4

Figure 4: Variability of Oxaliplatin-Induced Neuropathic Pain Symptoms in Each Cycle and Its Implications on the Management of Colorectal Cancer Patients: A Retrospective Study in South Western Sydney Local Health District Hospitals, Sydney, Australia 

Figure 4 | Variability of Oxaliplatin-Induced Neuropathic Pain Symptoms in Each Cycle and Its Implications on the Management of Colorectal Cancer Patients: A Retrospective Study in South Western Sydney Local Health District Hospitals, Sydney, Australia 